☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
All Posts by Date
PharmaShots Interview: Dermavant’s Philip Brown Shares Insight on the P-III (PSOARING 3) Study of Tapinarof
March 15, 2022
Celltrion Reports Results of CT-P39 (biosimilar, omalizumab) in P-I Study for Asthma and Chronic Idiopathic Urticaria
March 15, 2022
Sanofi Collaborates with Blackstone to Advance Sarclisa (isatuximab) for the Treatment of Multiple Myeloma
March 15, 2022
Novartis Presents New Data & Post-hoc Analyses of Zolgensma in Multiple Trials for the Treatment of Spinal Muscular Atrophy at MDA...
March 15, 2022
Ascentage Reports First Patient Dosing of Lisaftoclax (APG-2575) in P-II (APG2575CC201) Study for Chronic Lymphocytic Leukemia/Sma...
March 15, 2022
Dialectic Therapeutics’ DT2216 Receives the US FDA’s Orphan Drug Designation for the Treatment of T-Cell Lymphoma
March 15, 2022
Load more...
Back to Home
Stay Connected
LinkedIn
Twitter
Facebook
instagram
Youtube
Join the PharmaShots family of 12000+ subscribers
Newsletter
Subscribe Now
I accept the
Terms and Conditions